Pu et al. reported that naringin attenuated the obesity, dyslipidemia, fatty liver, liver dysfunction, and insulin resistance on high-fat diet (HFD)-fed mice, and its protection effect worked by phosphorylating AMPKα and insulin receptor substrate 1 (IRS 1) [41]. This evidence concerns the gene IRS1 and metabolic syndrome.